Day One Biopharmaceuticals

Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for patients of all ages with life-threatening diseases, particularly pediatric cancers. They generate revenue through the development and potential future sales of their proprietary drug candidates, which are designed to address significant unmet medical needs. Founded in 2018, the company is notable for its commitment to pediatric oncology, aiming to transform the treatment landscape for young patients by advancing innovative therapies from discovery through clinical development.

Recent Posts by Day One Biopharmaceuticals

1-20 of 93